Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide

Anesthesiology. 1998 Dec;89(6):1586-7. doi: 10.1097/00000542-199812000-00044.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intranasal
  • Adult
  • Female
  • Heart Defects, Congenital / complications*
  • Humans
  • Hypoxia / drug therapy*
  • Hypoxia / etiology
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / therapeutic use*

Substances

  • Nitric Oxide